CDRD provides a critical bridge between science and business – providing leading-edge academic discoveries with a path toward commercialization.
CDRD’s new headquarters in the University of British Columbia’s new Faculty of Pharmaceutical Sciences includes 35,000 sq ft of state-of-the-art drug development infrastructure.
“GSK is proud to be working in collaboration with CDRD and CDRD Ventures Inc. Unique collaborations of this nature provide a highly effective way of progressing and commercializing the innovative health research conducted at Canadian public institutions…”
- Dr. Rav Kumar, Vice-President, Regulatory Affairs, GlaxoSmithKline
CDRD BY THE NUMBERS:
“CDRD’s expertise in terms of it’s infrastructure and industry experience and focus, will greatly enhance the exposure and experience I get in academia. It’s a unique and valuable environment for those looking to work in industry”
- Dr. Clement Mugabe, CDRD MSFHR / Merck Post-Doctoral Fellow
“Collaborating with CDRD has provided Michael Riddell of York University and me with access to a new area of drug development infrastructure and expertise to tackle our drug development challenges.”
- Mladen Vranic, Laureate, Canadian Medical Hall of Fame, Professor Emeritus of Physiology and Medicine, University of Toronto
“We’ve brought on a number of graduates of the CDRD Training Program as full-time permanent employees here at STEMCELL. They are by far the most industry-prepared of all our new recruits.”
- Dr. Allen Eaves, President and CEO, STEMCELL Technologies Inc.
CDRD de-risks promising discoveries stemming from publicly-funded health research and transform them into commercially viable opportunities for the private sector.
CDRD represents a tremendous opportunity to translate early research discoveries into technologies that are investable by the private sector, ultimately leading to new therapies for patients.
The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).